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Malaria is a major infectious disease affecting millions of 
people worldwide annually. Plasmodium falciparum is the 
most virulent of the malaria parasites and its resistance to 
currently available drugs continues to grow, presenting an 
impediment to attempts to contain the disease. 
People with the sickle cell trait have a natural resistance to 
infection from P. falciparum. The sickle cell trait causes the 
protein sickle hemoglobin to be expressed which has a GLU 
mutated to a VAL in position six of the beta chain.1
Plasmepsin I and II are aspartic proteases found in P. 
falciparum that degrade hemoglobin in the red blood cell as 
source of nutrients.2
In this study, protein docking was used to identify and 
explore potential binding modes of P. falciparum plasmepsin 
I & II to normal and sickle hemoglobin. Molecular dynamics 
(MD) was used to determine the binding energies of the 
protein-protein complex. 
Protein Model: 
 The structure of plasmepsin I from Plasmodium 
falciparum was obtained from the Protein Data Bank
(PDB ID 3DRV)3.
 The structure of plasmepsin II from Plasmodium 
falciparum was obtained from the Protein Data Bank
(PDB ID 1IF4)4.
 The structure of deoxygenated normal human hemoglobin 
was obtained from the Protein Data Bank (PDB ID 2HHB)5.
 The structure of deoxygenated sickle hemoglobin was 
obtained from the Protein Data Bank (PDB ID 2HBS)6.
Docking Studies:
 VMD and Chimera7,8 were used to prepare the proteins for 
automated docking. For all the proteins, all hydrogens
were added and structures were minimized. 
 Plasmepsin I was docked with the dimer of normal and 
sickle hemoglobin. Plasmepsin II was docked with dimer 
and tetramer of both normal and sickle hemoglobin. 
 Docking was preformed using the ZDOCK Protein-Protein 
Docking Server9.
 Top 10 protein-protein complexes were generated and 
statistically analyzed. 
 Namd210 was used to minimize the energy and run MD 
simulations on selected complexes.
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 Plasmepsin I has potential binding modes with the dimer of 
normal and sickle hemoglobin which favorer the beta chain 
of hemoglobin.
 Plasmepsin II has potential binding modes with the dimer of 
normal and sickle hemoglobin on the alpha chain of 
hemoglobin.
 The binding modes of plasmepsin II to the tetramer of 
normal and sickle hemoglobin are to both alpha and beta 
chains.
 Plasmepsin I shows significantly more favorable binding to 
sickle hemoglobin dimer.
Docking of plasmepsin I & II to oxygenated normal and sickle 
hemoglobin.
Mutation study to determine the contribution of the 
identified critical residues in binding.
Detailed calculations to determine entropy contributions to 
the binding energy.
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Figure 5: Plasmepsin I with Normal Hemoglobin 
Dimer Binding Site
Figure 6: Plasmepsin II with Normal 
Hemoglobin Dimer Binding Site
Figure 7: Plasmepsin II with Normal Hemoglobin 
Tetramer Binding Site
Figure 1: Plasmepsin I with Normal Hemoglobin 
Dimer Binding Mode with the Beta Chain
Figure 2: Plasmepsin II with Sickle Hemoglobin 
Dimer Binding Mode with the Alpha Chain
Figure 3: Plasmepsin II with Normal Hemoglobin 
Tetramer Binding Mode with the Beta Chain
Plasmepsin I Plasmepsin II
Asn 108 Glu 74
Pro 110 Lys 238
Val 238 Pro 240
Phe 242 Phe 241
Ser 280 Pro 295
Figure 4:Critical Amino Acid Residues in Binding
(kcal/mol) 
x(103)
Normal 
Dimer
Sickle 
Dimer Tcal
Plasmepsin 
I -0.56 -1.24 7.473
Plasmepsin 
II 4.64 -2.89 2.585
Tcal 1.785 18.618 -------
Figure 8:Binding Energy in kcal/mol x103
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Figure 9:RMSD variation with Time-step Plot for 
Normal Dimer with Plasmepsin I
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Figure 10:RMSD variation with Time-step Plot 
for Sickle Dimer with Plasmepsin I
